Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives

Dig Liver Dis. 2018 Mar;50(3):220-225. doi: 10.1016/j.dld.2017.12.004. Epub 2017 Dec 14.

Abstract

The technique of hepatic arterial infusion (HAI) for the treatment of liver metastases from colorectal cancer has been developed over more than 30 years. Although the indications and protocols for this technique have evolved with time, HAI is not routinely performed in clinical practice. Studies have been heterogeneous, with different regimens of intra-arterial drugs, associated or not with systemic chemotherapy, and with unconvincing outcomes. Technical difficulties for catheter placement have limited the implementation of this method in routine practice. The aim of this review is to present recent studies, highlighting technical improvements and promising combinations of oxaliplatin-based HAI with systemic treatments. HAI is being investigated in both the metastatic setting - in the first line and beyond - and in the adjuvant setting, and we will discuss its potential place in current and future patient management.

Keywords: Colorectal neoplasms; Hepatic artery infusion; Liver metastases; Oxaliplatin.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Hepatic Artery
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin

Substances

  • Organoplatinum Compounds
  • Oxaliplatin